<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Wee, E.M. de</title>
    <link>http://repub.eur.nl/res/aut/17861/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Gynaecological and obstetric bleeding in moderate and severe von willebrand disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/33818/</link>
      <pubDate>2011-11-01T00:00:00Z</pubDate>
      <description>A nation-wide cross-sectional study was initiated to assess gynaecological and obstetrical symptoms in an unselected cohort of women with moderate and severe von Willebrand disease (VWD) in the Netherlands. A total of 423 women aged ≥16 years were included. Bleeding severity was measured using the Tosetto Bleeding Score (BS). Menorrhagia, defined as occurrence of ≥2 menorrhagia symptoms, was reported by 81%. Of all VWD women, 78% received any kind of treatment for menorrhagia and 20% underwent a hysterectomy predominantly because of severe menstrual bleeding. Over half of the women reported more blood loss than can be expected with a normal delivery. In 52% of reported pregnancy losses curettage was needed because of bleeding. Mean number of live births was 1.9, which is comparable with the general Dutch population. In conclusion, women with moderate or severe VWD frequently have menorrhagia in need of treatment, and 20% of the VWD women underwent a hysterectomy. Bleeding complications occurred in over 50% of the women after childbirth or pregnancy loss. Progeny seems not to be affected in women with moderate or severe VWD. </description>
    </item> <item>
      <title>Von Willebrand Disease in the Netherlands (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/26746/</link>
      <pubDate>2011-10-26T00:00:00Z</pubDate>
      <description>Based on previous epidemiologic studies it is estimated that in the Netherlands the
referral based prevalence of moderate to severe von Willebrand disease (VWD) is
approximately 1 in 10,000 (1650 patients). This does not include patients with mild
type 1 disease (VWF levels 30-50 U/dL), or individuals with borderline VWF levels
with a mild bleeding phenotype, of which the prevalence is higher and may even
reach 1:100 individuals. Despite the frequency of the disease only a limited number
of studies have been performed on clinical presentation, determinants of bleeding
phenotype and Quality of Life (QoL). Therefore we have initiated a nationwide study
on moderate and severe VWD in the Netherlands, the Willebrand in the Netherlands
study, the WiN study.</description>
    </item> <item>
      <title>Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/30717/</link>
      <pubDate>2011-10-06T00:00:00Z</pubDate>
      <description>Patients with von Willebrand disease (VWD), the most common inherited bleeding disorder, display large variation in bleeding tendency, which is not completely related to VWF levels. The cause of variability in clinical expression is largely unknown. The effect of plasma fibrinolytic capacity on bleeding tendency in VWD patients has not been investigated. We hypothesized that enhanced fibrinolysis may result in a more severe bleeding phenotype. Therefore, we measured the fibrinolytic potential in patients with moderate or severe VWD to investigate the contribution of fibrinolysis to the bleeding tendency. Fibrinolytic potential was measured as plasma clot lysis time (CLT) with and without addition of potato carboxypeptidase inhibitor (PCI) in 638 patients with moderate or severe VWD who participated in a nationwide multicentre cross-sectional study. Bleeding severity was measured using the Bleeding Score (BS).The CLTs were significantly longer, indicative of hypofibrinolysis, in men compared to women with VWD [106.2 (IQR 95.7-118.1) vs. 101.9 (IQR 92.8-114.0) min]. The CLTs prolonged with increasing age. No association was found between VWF or FVIII levels and CLT, or between VWF or FVIII levels and CLT+PCI. No association was observed for BS in a model with 10log-transformed CLT, adjusted for age, gender, VWF:Act and FVIII [b=6.5 (95%CI -0.3 to 13.4)]. Our study showed that the plasma fibrinolytic potential does not influence bleeding tendency in VWD patients and therefore does not explain the variability in bleeding phenotype in VWD. </description>
    </item> <item>
      <title>Impact of von Willebrand disease on health-related quality of life in a pediatric population (Article)</title>
      <link>http://repub.eur.nl/res/pub/23850/</link>
      <pubDate>2011-03-01T00:00:00Z</pubDate>
      <description>Background: Von Willebrand disease (VWD) is the most frequent inherited bleeding disorder. Whether VWD is associated with health-related quality of life (HR-QoL) in children is unknown. Objectives: This nationwide cross-sectional study measured HR-QoL in children with moderate or severe VWD. Our primary aim was to compare HR-QoL of VWD patients with that of reference populations. Additionally, we studied the impact of bleeding phenotype and VWD type on HR-QoL. Methods: HR-QoL was assessed with the Infant/Toddler QoL Questionnaire (0-5 years) and Child Health Questionnaire (6-15 years), and compared with reference population scores. Multivariate analysis was used to evaluate the influence of type of VWD and bleeding phenotype on HR-QoL scores. Results: Preschool children (0-5 years, n=46) with VWD had lower HR-QoL scores for general health perceptions and parental time than reference populations. School children (6-15 years, n=87) with VWD had lower scores for physical functioning, role functioning - emotional/behavioral, general health perceptions, and physical summary. Type of VWD was associated with HR-QoL in school children for bodily pain, general health perceptions, parental emotion, family activities, and physical summary. Scores of children with type 3 VWD were, on average, 15 points lower than those of the reference population on the above-mentioned scales. A more severe bleeding phenotype was associated with a lower score on 11/15 physical, emotional and social scales. Conclusion: HR-QoL is lower in VWD children than in reference populations, in particular in school children. The negative impact of VWD is sensitive to type of VWD and bleeding phenotype; as well as physical scales, emotional and social scales are affected. </description>
    </item> <item>
      <title>Health-related quality of life among adult patients with moderate and severe von Willebrand disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/28549/</link>
      <pubDate>2010-07-01T00:00:00Z</pubDate>
      <description>Background: von Willebrand Disease (VWD) is the most frequent inherited bleeding disorder. It is unknown how this disorder affects quality of life. Objectives: This nationwide multicenter cross-sectional study determined health-related quality of life (HR-QoL) in adult patients with moderate or severe VWD, and assessed whether bleeding severity and type of VWD are associated with HR-QoL. Methods: HR-QoL was assessed using the Short Form (SF)-36, and bleeding severity was measured using the Bleeding Score (BS). Results: Five hundred and nine patients participated; 192 males and 317 females, median age and range 45 (16-87) and 47 (16-84) years, respectively. Compared with the general population, HR-QoL in VWD patients was lower in the vitality domain (61 vs. 66 P &lt; 0.001 for females, 67 vs. 72 P &lt; 0.001 for males). Patients with the most severe bleeding phenotype (highest quartile BS, BS &gt; 17) had a lower HR-QoL in eight domains than patients with a less severe bleeding type (lowest quartile BS, BS &lt; 7) in the univariate analysis. After adjustment for age, gender, co-morbidity and employment/educational status, a more severe bleeding phenotype was associated with lower scores on the domains of physical functioning, role limitations due to physical functioning, bodily pain, general health, social functioning and physical component summary. Conclusions: HR-QoL is lower in VWD patients compared with the general population. HR-QoL is strongly associated with bleeding phenotype. </description>
    </item> <item>
      <title>Transient focal cerebral ischaemia and bilateral pulmonary embolism after desmopressin treatment for von Willebrand's disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/15148/</link>
      <pubDate>2008-09-12T00:00:00Z</pubDate>
      <description></description>
    </item>
  </channel>
</rss>